For Research Use Only - Not for Human Consumption
A vial label is not AOD 9604 batch documentation. For a research material to be traceable, the buyer needs a document set that ties the specific vial or lot to an analytical result, a defined material identity, and a controlled release decision. A generic certificate with no batch number, method details, or test date does not establish that connection.
AOD-9604 is generally described in research catalogs as the C-terminal 16-amino-acid fragment corresponding to residues 176-191 of human growth hormone. Its reported sequence is Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe, with an approximate molecular weight of 1,815.1 g/mol. Documentation should confirm that the material tested is consistent with the ordered analyte, presentation, and batch.
For Research Use Only - Not for Human Consumption. This material is intended solely for legitimate laboratory research and analytical work. It is not a food, drug, dietary supplement, or product for human or veterinary use.
Author: Research Team at The Peptide Source
Why batch-specific records matter
Research workflows depend on comparability. If a result differs between vials, researchers need a defensible way to examine whether the source material, handling history, analytical method, or experimental conditions changed. Batch-specific records provide the starting point for that review.
A supplier statement such as “99% purity” is useful only when the claim is connected to a lot number and a reported analytical method. A proper certificate of analysis, or COA, should identify the tested batch, date the analysis, name the analyte, and report the result in a way that can be reviewed against the material received.
This does not mean every project needs the same documentation depth. Early-stage analytical screening may require identity confirmation and chromatographic purity data. A program maintaining reference lots or comparing multiple incoming lots may also require raw chromatograms, mass spectra, retain-sample policy, and documented packaging controls. The right standard depends on the research protocol, but undocumented material is difficult to qualify under any standard.
AOD 9604 batch documentation checklist
1. Match the batch number to the vial
The batch or lot number on the COA must match the batch or lot number printed on the vial label and, where applicable, the outer packaging. This is the most basic verification step and the one that makes every other document relevant.
Check the product name, concentration or fill amount, and unit count at the same time. A COA for AOD-9604 cannot substantiate a different peptide, even if the purity result is high. If the vial identifier is missing, obscured, or inconsistent with the document, quarantine the material from active research inventory until the discrepancy is resolved.
2. Confirm identity testing
For a peptide of this size, identity is commonly evaluated using LC-MS or a comparable mass-spectrometric method. The reported molecular mass should align with the expected mass of the stated sequence, allowing for the method’s stated mass accuracy and relevant ion forms.
A useful identity record states the analytical technique, observed mass, expected mass, acceptance criterion, result, and analyst or quality authorization. A simple “Pass” result is less informative than a record that shows the basis for the pass decision.
Sequence confirmation may be supported by synthesis records or more detailed characterization, depending on the supplier’s quality system. For routine incoming qualification, a batch-matched LC-MS result is often the practical document researchers request first.
3. Review purity as a measured result
Purity is commonly reported by HPLC or UPLC using UV detection, frequently as area percent under defined integration conditions. A claim of >99% HPLC purity should be batch-specific and should identify the method or chromatogram used to generate the value.
Review the reported purity alongside the chromatogram, not in isolation. Peak shape, secondary peaks, retention time, integration parameters, and the report date all add context. A single dominant peak can support a purity assessment, but it does not independently establish sequence identity, residual solvent content, moisture level, or bioburden status.
For research purchasing, ask whether the reported number is area percent, assay, or another calculation. These measurements are not interchangeable. Clear documentation prevents a supplier’s marketing specification from being mistaken for a fully defined analytical result.
4. Check formulation and presentation details
AOD-9604 documentation should state whether the material is supplied as lyophilized powder or in another form. The record should identify the nominal fill amount and any declared excipients. When no excipients are listed, the document should say so rather than leaving the composition ambiguous.
Storage instructions should also be explicit. Researchers should follow the supplier’s batch-specific label and documentation, maintain controlled inventory records, and avoid assigning storage conditions based solely on a different lot or a third-party listing. Documentation supports traceability; it does not replace a laboratory’s own handling procedures.
What a usable COA contains
A usable COA is a controlled quality document, not a marketing graphic. At minimum, it should show the supplier or testing laboratory name, product identity, batch number, test date, and a clear disposition such as pass, fail, or released. It should also include the specifications and actual results for the reported tests.
The strongest documentation package includes a COA paired with batch-matched chromatographic and mass-spectrometric evidence. If third-party testing is represented, distinguish between a manufacturer-issued COA and an independent laboratory report. Both can be useful, but they answer different traceability questions.
A manufacturer COA shows the release information issued by the producer. Third-party verification provides an additional analytical checkpoint when the report is tied to the same batch. Researchers should request clarification when a vendor presents a third-party report without the corresponding lot number, date, analyte name, or laboratory identification.
Document controls that reduce avoidable errors
Quality review is not limited to test results. Version control, document dates, signatures or electronic approvals, and retained records affect whether a COA can be audited later. A report with a batch number but no issue date is weaker than one with a complete release trail.
Chain-of-custody records are particularly useful when material changes hands between manufacturing, testing, fulfillment, and the receiving laboratory. The record does not need to expose proprietary operational details. It should, however, allow the supplier and researcher to determine which batch was shipped, when it was released, and whether the documentation package applies to that shipment.
At Peptide Source, the practical standard for a research-grade purchase is straightforward: review batch-specific COA availability before placing the material into a research workflow, then retain the relevant document with the laboratory’s receiving records. Fast fulfillment is useful, but speed does not substitute for verification.
> Compliance Notice
>
> For Research Use Only - Not for Human Consumption. AOD-9604 and all associated batch records are intended for laboratory research, analytical evaluation, and lawful institutional or independent research use only. Do not use this material in humans or animals. Buyers are responsible for confirming that their intended work, storage, handling, and disposal practices comply with applicable requirements.
Questions to ask before accepting a batch
Before accepting an AOD-9604 shipment into inventory, ask whether the COA is batch-specific, whether the vial number matches the document, and whether LC-MS identity plus HPLC or UPLC purity results are available. If the study requires tighter controls, ask for chromatograms, mass spectra, testing laboratory information, and the document revision date.
It is also reasonable to ask how long batch records are retained and whether a replacement COA can be issued if the original file is misplaced. A reliable documentation process should not depend on an image captured from a product page or an unverified file shared between buyers.
Can a generic COA be used for more than one lot?
No. A generic example can show the format of a supplier’s documentation, but it cannot verify the identity or purity result of a different batch. Qualification should rely on the report assigned to the received lot.
Does a high HPLC purity result prove everything about the material?
No. HPLC purity is one analytical attribute. Identity, formulation, fill amount, and other attributes require their own documented basis.
What should be retained in laboratory records?
Retain the batch-matched COA, analytical attachments provided for that lot, receiving date, vial identifier, storage record, and any internal acceptance decision. This creates a usable audit trail if a result later requires review.
For Research Use Only - Not for Human Consumption. The most useful batch documentation is the documentation that remains traceable after the shipment is opened, logged, and placed into a controlled research inventory.